- Home
- LKCO vs MBRX Comparison
LKCO vs MBRX Comparison
Compare LKCO & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKCO
- MBRX
- Stock Information
- Founded
- LKCO 2009
- MBRX 2015
- Country
- LKCO China
- MBRX United States
- Employees
- LKCO N/A
- MBRX N/A
- Industry
- LKCO EDP Services
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- LKCO Technology
- MBRX Health Care
- Exchange
- LKCO Nasdaq
- MBRX Nasdaq
- Market Cap
- LKCO 5.5M
- MBRX 5.7M
- IPO Year
- LKCO N/A
- MBRX 2016
- Fundamental
- Price
- LKCO $1.69
- MBRX $1.88
- Analyst Decision
- LKCO
- MBRX Strong Buy
- Analyst Count
- LKCO 0
- MBRX 2
- Target Price
- LKCO N/A
- MBRX $24.00
- AVG Volume (30 Days)
- LKCO 187.4K
- MBRX 62.3K
- Earning Date
- LKCO 10-22-2024
- MBRX 11-08-2024
- Dividend Yield
- LKCO N/A
- MBRX N/A
- EPS Growth
- LKCO N/A
- MBRX N/A
- EPS
- LKCO N/A
- MBRX N/A
- Revenue
- LKCO $5,389,818.00
- MBRX N/A
- Revenue This Year
- LKCO N/A
- MBRX N/A
- Revenue Next Year
- LKCO N/A
- MBRX N/A
- P/E Ratio
- LKCO N/A
- MBRX N/A
- Revenue Growth
- LKCO N/A
- MBRX N/A
- 52 Week Low
- LKCO $1.43
- MBRX $0.40
- 52 Week High
- LKCO $8.00
- MBRX $6.24
- Technical
- Relative Strength Index (RSI)
- LKCO 43.31
- MBRX 47.84
- Support Level
- LKCO $1.90
- MBRX $1.65
- Resistance Level
- LKCO $2.15
- MBRX $1.99
- Average True Range (ATR)
- LKCO 0.26
- MBRX 0.20
- MACD
- LKCO -0.03
- MBRX 0.04
- Stochastic Oscillator
- LKCO 6.67
- MBRX 71.79
About LKCO Luokung Technology Corp
Luokung Technology Corp is a spatial-temporal intelligent big data services company, as well as a provider of LBS for various industries in China. It has established city-level and industry-level holographic spatial-temporal digital twin systems and actively serves industries including smart transportation (autonomous driving, smart highway and vehicle-road collaboration), natural resource asset management (carbon neutral and environmental protection remote sensing data service), and LBS smart industry applications (mobile Internet LBS, smart travel, smart logistics, new infrastructure, smart cities, emergency rescue, among others).
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.